User Stats

Rank: 412
Karma Score: 1,549
Joined: January 13, 2022
Submitted Stories: 482
Published Stories: 0
Comments: 24
Votes: 482
Group Name
Membership unavailable

Following

No Following!

Followers

No Follower!

Stories

What are the market dynamics in the Finland renewable energy market

The Energy Authority – ‘Energiavirasto’ is the primary authority for the implementation of Finland’s renewable energy policies and of the European Union’s (EU) directives related to renewable energy in the country. The Energy authority conducts auctions for renewable power projects and governs the Feed-in Tariff scheme (FiT) in the country. It is to be noted that FiTs for new renewable power projects were stopped in 2018. It was replaced by competitive bidding/auctions and is currently the major subsidy for new renewable power projects. The Energy Authority also manages the guarantee of origin system for renewable electricity, manages compliance with the sustainability of biofuels and fuel quality.

In November 2016, Finland presented a new report on the National Energy and Climate Strategy for 2030 and adopted it in 2017. Its main objective was to achieve the targets specified in the Government Programme and adopted in the EU for 2030, and to systematically set the course for achieving the 2050 targets. The strategy also phased out FiT mechanism and introduced auction scheme to make renewable energy more cost effective. The country also aims at phasing out coal powered plants by 2030. To this regard, a law was passed on 29th March 2019, banning the use of coal for electricity generation purposes effective from 1st May 2029.

Virtual Care and Telemedicine in Healthcare – Thematic Research

Virtual care is the intersection between digital technologies and healthcare delivery systems. By integrating new and existing digital technologies such as telehealth, connected medical devices, remote monitoring, mobile device apps, and electronic health records, healthcare systems can expand their services to patient populations whenever and however is most convenient to each individual patient. By allowing patients to interact with their healthcare providers digitally, virtual care encourages those patients to seek out continual care without having to incur the consequences of unnecessary travel, limited access to care services, or lost days of work.

Gastroparesis Marketed and Pipeline Drugs Assessment Clinical Trials and Competitive Landscape

The gastroparesis pipeline consists of 17 pharmaceuticals spanning all stages of development, with approximately 90% of the drugs in early-stage development. Antagonists targeting the D2 receptor are expected to remain an important mechanism of action within the gastroparesis space. The report provides a data-driven overview of the current and future competitive landscape in gastroparesis therapeutics.

Gastroparesis is a chronic disease characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach. Patients with gastroparesis experience chronic symptoms with episodes of exacerbation, which typically include postprandial fullness, nausea, vomiting, and upper abdominal pain. Patients may also present with gastroparesis-like symptoms without delayed gastric emptying, complicating the identification of patients with the disease. The overlap of upper gastrointestinal symptoms makes the distinction between gastroparesis and other disorders, such as functional dyspepsia, more challenging.

Blockchain Market Size, Share, Trends, Analysis Report by Application (Supply Chain Management, Cross-Border Payments, Lot lineage, Identity Management) Vertical (BFSI, Transport & Logistics, Cross-sector, Retail, Healthcare, Government), Region, and Segment Forecast, 2021-2030

The blockchain market size was valued at US$6.1 billion in 2021 and is expected to grow at a CAGR of 62.4% during 2022-2030. The blockchain market report provides an executive-level overview of the current blockchain market worldwide, with detailed forecasts of key indicators up to 2030.

Smart Robotics – How Mobile Robots can Improve Productivity

Mobile robots are software-controlled machines that leverage mechatronic technologies to identify and move around their environment. They can operate by combining technologies such as artificial intelligence (AI) with mechanical robotic elements like legs, tracks, and wheels. Mobile robots are gaining popularity in a variety of commercial sectors. They are implemented to help with various job functions and even to perform operations that would be difficult or unsafe for human workers to accomplish.

The smart robotics industry research report examines how enterprises and startups are developing and adopting mobile robotics technology across key sectors to improve productivity in the land, water, and air with automated and autonomous features.

Anxiety Marketed and Pipeline Drugs Assessment Clinical Trials and Competitive Landscape

Anxiety disorders are the most common mental disorders and manifest as disturbances of mood, thinking behavior, and physiological activity. They include panic disorder, agoraphobia, generalized anxiety disorder (GAD), specific phobia, social anxiety disorder (SAD), acute stress disorder, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). The common symptoms of anxiety are disturbances of sleep and concentration as well as problems with social and/or occupational functioning. The anxiety is associated with restlessness, feeling “on edge,” being easily fatigued, difficulty concentrating, irritability, and muscle tension.

The anxiety marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in anxiety therapeutics.

Nontuberculous Mycobacteria NTM Market Size and Trend Report including Epidemiology and Pipeline Analysis

Diagnosed prevalent cases of Nontuberculous Mycobacteria (NTM) infections are expected to increase in the US, the UK, and Japan by 0.88% between 2021 and 2031. Treatment regimens for NTM are a combination therapy of at least three different antibiotics, frequently including macrolides. The greatest unmet needs within the NTM market are new antibiotics with improved success rates and minimal toxicity. The late stage NTM pipeline consists of seven drugs, six of which are first in class therapies. The NTM market in the US, the UK, and Japan was valued at $8.59 Billion in 2021. The market is projected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $11.04 Billion by 2031.

Trauma Fixation Pipeline Report including Stages of Development Segments Region and Countries

Trauma fixation devices are used for the treatment of fractures. These devices provide support for aligning, stabilizing, and immobilization of fractured bones. Trauma fixation devices are broadly classified into two types – internal fixators and external fixators.

The trauma fixation pipeline market research report provides comprehensive information about the Trauma Fixation pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Optical Coherence Tomography OCT Pipeline Report including Stages of Development

Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. GlobalData's Medical Devices sector report, “Optical Coherence Tomography (OCT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Optical Coherence Tomography (OCT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Optical Coherence Tomography (OCT) report provides key information and data related to: Extensive coverage of the Optical Coherence Tomography (OCT) under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates Reviews of major players involved in the pipeline product development.

Education Technology EdTech Market Size Share and Trends Analysis Report by Region

Over the last few years, the Edtech market has gained traction attributed to technological advancements in traditional teaching institutions through the adoption of sophisticated learning tools to improvise classroom-level education. Additionally, the collaborative approach between Edtech companies, educational institutions, and enterprises has transformed the learning process over the last few years. For instance, in October 2021, Anthology, one of the higher education software solutions provider completed its merger with Blackboard Inc., one of the globally recognized EdTech software and solutions company to provide enhanced personalized experiences and insights to students and corporates across their learning lifecycle. Further, the adoption of digital devices such as tablets, and software-based assessment tools and game-based learning tools also helps learners enhance visual skills and improve interaction as well as cooperation with peers.

United Kingdom UK Travel Insurance – Distribution and Marketing 2021

The UK travel insurance industry is expected to grow at a CAGR of more than 4% by 2025. The success of the UK’s COVID-19 vaccination program allowed fully vaccinated residents to travel to certain countries with fewer restrictions from August 2021. This is expected to increase travel insurance purchases and premiums as consumers look for more comprehensive coverage.

At a time when COVID-19 is changing consumer behaviors, the UK travel insurance report explores how purchasing preferences in the market are changing. It discovers what is most influential to customers when purchasing a travel insurance policy and reveals the most popular providers in the market. New trends and innovations are highlighted, as well as the key factors that will influence the market over the next few years.

Visa – Enterprise Tech Ecosystem Series

Visa has been focusing on using technologies like blockchain, cloud, and big data to enhance operations and improve customer service. The annual ICT spending of Visa was estimated at $2.9 billion in 2021. A major share of this spending is earmarked for acquiring ICT services, software, and hardware from vendors. It is a global digital payment technology company catering to individual and commercial clients, financial institutions, government entities, and merchants. It facilitates global e-commerce through digital payments and information. The company’s transaction processing network, VisaNet, manages the clearing, authorization, and settlement of payment transactions. Its portfolio consists of payment cards, commercial payments, transaction processing services, digital services, and merchant solutions.

Life Insurance Corporation of India 2022 – Digital Transformation Strategies

Life Insurance Corporation of India (LIC) has been focusing on using artificial intelligence & machine learning, mobile technologies and cloud to digitally transform its operations. The annual ICT spending of LIC was estimated at $4.7 billion for 2021. A major share of this spending is earmarked for acquiring software, hardware and consulting services from vendors. LIC is a provider of life insurance plans. The company offers endowment plans, money back plans, term assurance plans, pension plans, unit-linked plans, group schemes, and health insurance plans.

The LIC digital transformation strategies report will act as a reference point to understand a company/competitor’s digital strategy. It will also help in understanding the digital preparedness of the company against its peers. Information included in these reports are sourced from a mix of our very own internal database and authentic secondary research links such as company’s annual report, presentations, press releases etc. The report covers overview of the company, its digital transformation strategies, technology focus areas, technology partnerships, technology introductions, and ICT spending among others.

Eosinophilic Esophagitis Market Size and Trend Report including Epidemiology and Pipeline Analysis

The eosinophilic esophagitis (EoE) market in the US was valued at $156.7 million in 2020. The market is projected to grow at a CAGR of more than 25% during the forecast period. The COVID-19 pandemic did not impact the EoE market in 2020. Although the uptake of high-priced biologics is expected to be slow, they are expected to capture significant growth revenue over the next 10 years.

A large number of symptomatic treatments are currently used off-label. The most frequently used drug classes are proton pump inhibitors and corticosteroids. The most commonly used off-label proton pump inhibitors for EoE are omeprazole and pantoprazole. The most commonly corticosteroids used off-label for EoE are budesonide and fluticasone propionate. The greatest unmet needs within the EoE market are lack of data, more effective or curative therapies, increased awareness and education, and more options for the pediatric population.

Giant Cell Arteritis Temporal Arteritis-Cranial Arteritis-Horton Disease Drugs in Development by Stages Target MoA

Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Papillary Tumor Drugs in Development by Stages Target MoA RoA Molecule Type and Key Players

Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Papillary Tumor pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Papillary Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Lymphoblastic Lymphoma Drugs in Development by Stages Target MoA RoA Molecule Type and Key Players

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lymphoblastic Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lymphoblastic Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.